Novan, Inc. (NOVN)
After hours:
| Previous close | 1.0500 |
| Open | 1.0900 |
| Bid | 1.1700 x 800 |
| Ask | 1.1900 x 900 |
| Day's range | 1.0500 - 1.1900 |
| 52-week range | 0.7900 - 4.0900 |
| Volume | |
| Avg. volume | 205,972 |
| Market cap | 28.988M |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2960 |
| Earnings date | 15 May 2023 - 19 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.50 |
- GlobeNewswire
Novan Announces Closing of $6.0 Million Registered Direct Offering
DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the closing of the issuance and sale in the Company’s previously announced registered direct offering of an aggregate of (i) 5,042,017 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and (ii) warrants (the “Common Warrants”) to purchase up to 5,042,017 shares of common stock, at an effective combined purchase price of $1.19 per share
- GlobeNewswire
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
Presentation with live webcast today, March 14th at 10:40 AM ETDURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will present at the virtual Oppenheimer 33rd Annual Healthcare Conference today, March 14, 2023 at 10:40 AM ET. In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the
- GlobeNewswire
Novan Announces $6.0 Million Registered Direct Offering
DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it has entered into definitive agreements for the issuance and sale in a registered direct offering of an aggregate of (i) 5,042,017 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and (ii) warrants (the “Common Warrants”) to purchase up to 5,042,017 shares of common stock, at an effective combined purchase price of $1.19 per sh
